20-54164552-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_000782.5(CYP24A1):​c.744G>A​(p.Thr248Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.111 in 1,614,026 control chromosomes in the GnomAD database, including 12,269 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.095 ( 1008 hom., cov: 32)
Exomes 𝑓: 0.11 ( 11261 hom. )

Consequence

CYP24A1
NM_000782.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -4.32

Publications

84 publications found
Variant links:
Genes affected
CYP24A1 (HGNC:2602): (cytochrome P450 family 24 subfamily A member 1) This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This mitochondrial protein initiates the degradation of 1,25-dihydroxyvitamin D3, the physiologically active form of vitamin D3, by hydroxylation of the side chain. In regulating the level of vitamin D3, this enzyme plays a role in calcium homeostasis and the vitamin D endocrine system. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
CYP24A1 Gene-Disease associations (from GenCC):
  • hypercalcemia, infantile, 1
    Inheritance: AR Classification: STRONG, LIMITED Submitted by: G2P, Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae)
  • autosomal recessive infantile hypercalcemia
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 20-54164552-C-T is Benign according to our data. Variant chr20-54164552-C-T is described in ClinVar as Benign. ClinVar VariationId is 338825.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-4.32 with no splicing effect.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.352 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CYP24A1NM_000782.5 linkc.744G>A p.Thr248Thr synonymous_variant Exon 6 of 12 ENST00000216862.8 NP_000773.2 Q07973-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CYP24A1ENST00000216862.8 linkc.744G>A p.Thr248Thr synonymous_variant Exon 6 of 12 1 NM_000782.5 ENSP00000216862.3 Q07973-1

Frequencies

GnomAD3 genomes
AF:
0.0948
AC:
14411
AN:
152056
Hom.:
1007
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0409
Gnomad AMI
AF:
0.173
Gnomad AMR
AF:
0.0967
Gnomad ASJ
AF:
0.102
Gnomad EAS
AF:
0.366
Gnomad SAS
AF:
0.172
Gnomad FIN
AF:
0.0652
Gnomad MID
AF:
0.123
Gnomad NFE
AF:
0.104
Gnomad OTH
AF:
0.103
GnomAD2 exomes
AF:
0.124
AC:
31139
AN:
251404
AF XY:
0.126
show subpopulations
Gnomad AFR exome
AF:
0.0398
Gnomad AMR exome
AF:
0.103
Gnomad ASJ exome
AF:
0.119
Gnomad EAS exome
AF:
0.367
Gnomad FIN exome
AF:
0.0734
Gnomad NFE exome
AF:
0.104
Gnomad OTH exome
AF:
0.113
GnomAD4 exome
AF:
0.113
AC:
165407
AN:
1461852
Hom.:
11261
Cov.:
33
AF XY:
0.115
AC XY:
83343
AN XY:
727230
show subpopulations
African (AFR)
AF:
0.0385
AC:
1290
AN:
33480
American (AMR)
AF:
0.103
AC:
4619
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.117
AC:
3056
AN:
26134
East Asian (EAS)
AF:
0.380
AC:
15074
AN:
39698
South Asian (SAS)
AF:
0.158
AC:
13640
AN:
86258
European-Finnish (FIN)
AF:
0.0760
AC:
4058
AN:
53418
Middle Eastern (MID)
AF:
0.129
AC:
741
AN:
5766
European-Non Finnish (NFE)
AF:
0.104
AC:
115657
AN:
1111984
Other (OTH)
AF:
0.120
AC:
7272
AN:
60390
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.461
Heterozygous variant carriers
0
9915
19830
29746
39661
49576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4464
8928
13392
17856
22320
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0947
AC:
14415
AN:
152174
Hom.:
1008
Cov.:
32
AF XY:
0.0958
AC XY:
7129
AN XY:
74380
show subpopulations
African (AFR)
AF:
0.0408
AC:
1696
AN:
41528
American (AMR)
AF:
0.0969
AC:
1482
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.102
AC:
354
AN:
3468
East Asian (EAS)
AF:
0.366
AC:
1885
AN:
5156
South Asian (SAS)
AF:
0.172
AC:
831
AN:
4822
European-Finnish (FIN)
AF:
0.0652
AC:
690
AN:
10584
Middle Eastern (MID)
AF:
0.126
AC:
37
AN:
294
European-Non Finnish (NFE)
AF:
0.104
AC:
7065
AN:
68002
Other (OTH)
AF:
0.103
AC:
217
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
642
1284
1926
2568
3210
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
172
344
516
688
860
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.104
Hom.:
3874
Bravo
AF:
0.0945
EpiCase
AF:
0.100
EpiControl
AF:
0.110

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Hypercalcemia, infantile, 1 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
0.23
DANN
Benign
0.65
PhyloP100
-4.3
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs6068816; hg19: chr20-52781091; COSMIC: COSV107247184; COSMIC: COSV107247184; API